📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: MiroBio

1.1 - Company Overview

MiroBio Logo

MiroBio

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of an antibody platform based on University of Oxford research into immune cell communication and activation, creating antibodies that leverage natural signalling mechanisms to restore immune system balance and control.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to MiroBio

Gesynta Pharma Logo

Gesynta Pharma

HQ: Sweden Website
  • Description: Provider of clinical-stage pharmaceutical R&D developing mPGES-1–inhibiting drug candidates to reduce inflammation and pain. Pipeline includes vipoglanstat (GS-248), a non-hormonal treatment for endometriosis in phase II, and GS-073 for chronic inflammatory pain entering phase I. Research originates from Karolinska Institutet; GS-073 from AstraZeneca.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Gesynta Pharma company profile →
Upstream Bio Logo

Upstream Bio

HQ: United States Website
  • Description: Provider of antibody therapies targeting the TSLP receptor, developing verekitug (UPB-101), a monoclonal antibody in Phase 2 trials for severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP), and conducting research on Thymic Stromal Lymphopoietin (TSLP) as a driver of inflammatory responses in allergic and inflammatory diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Upstream Bio company profile →
Graviton Logo

Graviton

HQ: United States Website
  • Description: Provider of clinical-stage biotech therapies, developing selective ROCK2 inhibitors for fibrotic, autoimmune and CNS diseases; a C6 monoclonal antibody for neurodegenerative diseases; and DYRK inhibitors for diabetes, neurological disorders and cancers. Conducts clinical trials and partners with Ovid Therapeutics and Sino Biopharmaceutical for development and commercialization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Graviton company profile →
Cell IDx Logo

Cell IDx

HQ: United States Website
  • Description: Provider of multiplexed cellular immunodiagnostics solutions, developing highly sensitive and specific reagents for research and clinical immunohistochemistry, and offering UltraPlex technology for multiplex chromogenic and fluorescent tissue staining suitable for high-throughput biomarker tissue profiling.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cell IDx company profile →
Epiva Logo

Epiva

HQ: United States Website
  • Description: Provider of immuno-microbiome therapeutics, developing immunobiotic therapeutics through a platform from Flagship VentureLabs, the innovation foundry of Flagship Ventures.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Epiva company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for MiroBio

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to MiroBio

2.2 - Growth funds investing in similar companies to MiroBio

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for MiroBio

4.2 - Public trading comparable groups for MiroBio

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to MiroBio

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About MiroBio

What does MiroBio do?

MiroBio is a provider of an antibody platform based on University of Oxford research into immune cell communication and activation, creating antibodies that leverage natural signalling mechanisms to restore immune system balance and control.

Who are MiroBio's competitors?

MiroBio's competitors and similar companies include Gesynta Pharma, Upstream Bio, Graviton, Cell IDx, and Epiva.

Where is MiroBio headquartered?

MiroBio is headquartered in United Kingdom.

How many employees does MiroBio have?

MiroBio has 1,000 employees 🔒.

When was MiroBio founded?

MiroBio was founded in 2010 🔒.

What sector and industry vertical is MiroBio in?

MiroBio is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for MiroBio

Who are the top strategic acquirers in MiroBio's sector and industry

Top strategic M&A buyers and acquirers in MiroBio's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for MiroBio?

Top strategic M&A buyers groups and sectors for MiroBio include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in MiroBio's sector and industry vertical

Which are the top PE firms investing in MiroBio's sector and industry vertical?

Top PE firms investing in MiroBio's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in MiroBio's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in MiroBio's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in MiroBio's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to MiroBio include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in MiroBio's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for MiroBio?

The key public trading comparables and valuation benchmarks for MiroBio include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for MiroBio for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for MiroBio with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in MiroBio's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for MiroBio with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in MiroBio's' sector and industry vertical?

Access recent funding rounds and capital raises in MiroBio's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for MiroBio